Ecto-5′-nucleotidase (CD73) decreases mortality and organ injury in sepsis

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4256-4267

  Haskó, György ^a,b   Csóka, Balázs ^a   Koscsó, Balázs ^a   Chandra, Rachna ^a   Pacher, Pál ^c   Thompson, Linda F ^d   Deitch, Edwin A ^a   Spolarics, Zoltán ^a   Virág, László ^b   Gergely, Pál ^b   Rolandelli, Rolando H ^e   Németh, Zoltán H ^a,e  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e MORRISTOWN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE; CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; FLOW CYTOMETRY; KIDNEY DYSFUNCTION; LUNG INJURY; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN INJURY; PERITONEUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; SEPSIS; ANIMAL; CELL SEPARATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; WESTERN BLOTTING;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; BLOTTING, WESTERN; CELL SEPARATION; CHEMOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MICE; MICE, KNOCKOUT; SEPSIS;

EID: 80054769141     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003379     Document Type: Article

References (78)

1. Bone, R. C. 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125: 680-687. (Pubitemid 126450605)
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310. (Pubitemid 32641789)
3. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554. (Pubitemid 36437931)
4. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
5. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. The enigma of sepsis. J. Clin. Invest. 112: 460-467. (Pubitemid 38056327)
6. Benjamim, C. F., C. M. Hogaboam, and S. L. Kunkel. 2004. The chronic consequences of severe sepsis. J. Leukoc. Biol. 75: 408-412. (Pubitemid 38316370)
7. Oberholzer, A., C. Oberholzer, and L. L. Moldawer. 2002. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 30: S58-S63. (Pubitemid 34131163)
8. Ayala, A., and I. H. Chaudry. 1996. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6 (Suppl. 1): S27-S38. (Pubitemid 126727793)
9. Németh, Z. H., B. Csóka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Haskó. 2006. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J. Immunol. 176: 5616-5626.
10. Haskó, G., C. Szabó, Z. H. Németh, V. Kvetan, S. M. Pastores, and E. S. Vizi. 1996. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157: 4634-4640. (Pubitemid 126449386)
11. Haskó, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch, J. G. Mabley, A. Marton, and C. Szabó. 2000. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
12. Németh, Z. H., S. J. Leibovich, E. A. Deitch, B. Sperlágh, L. Virág, E. S. Vizi, C. Szabó, and G. Haskó. 2003. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. Biochem. Biophys. Res. Commun. 312: 883-888. (Pubitemid 37490900)
13. Németh, Z. H., S. J. Leibovich, E. A. Deitch, E. S. Vizi, C. Szabó, and G. Hasko. 2003. cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine. J. Pharmacol. Exp. Ther. 306: 1042-1049. (Pubitemid 37025312)
14. Németh, Z. H., C. S. Lutz, B. Csóka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Haskó. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated post-transcriptional mechanism. J. Immunol. 175: 8260-8270. (Pubitemid 41798391)
15. Németh, Z. H., D. Bleich, B. Csóka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabó, B. N. Cronstein, and G. Haskó. 2007. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21: 2379-2388. (Pubitemid 47230668)
16. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527-552. (Pubitemid 33136237)
17. Jacobson, K. A., and Z. G. Gao. 2006. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5: 247-264. (Pubitemid 43336037)
18. Sitkovsky, M. V., D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, A. Ohta, and M. Thiel. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22: 657-682. (Pubitemid 38680437)
19. Zhong, H., L. Belardinelli, T. Maa, and D. Zeng. 2005. Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 32: 2-8. (Pubitemid 40053298)
20. Chunn, J. L., A. Mohsenin, H. W. Young, C. G. Lee, J. A. Elias, R. E. Kellems, and M. R. Blackburn. 2006. Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L579-L587. (Pubitemid 43725103)
21. Haskó, G., E. A. Deitch, C. Szabó, Z. H. Németh, and E. S. Vizi. 2002. Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr. Opin. Pharmacol. 2: 440-444. (Pubitemid 34830976)
22. Haskó, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39. (Pubitemid 38032805)
23. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170. (Pubitemid 30470299)
24. Zhong, H., L. Belardinelli, T. Maa, I. Feoktistov, I. Biaggioni, and D. Zeng. 2004. A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 30: 118-125. (Pubitemid 38085266)
25. Martin, C., M. Leone, X. Viviand, M. L. Ayem, and R. Guieu. 2000. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit. Care Med. 28: 3198-3202.
26. Gallos, G., T. D. Ruyle, C. W. Emala, and H. T. Lee. 2005. A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. Am. J. Physiol. Renal Physiol. 289: F369-F376. (Pubitemid 41003666)
27. Lee, H. T., M. Kim, J. D. Joo, G. Gallos, J. F. Chen, and C. W. Emala. 2006. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R959-R969. (Pubitemid 44498436)
28. Csóka, B., Z. H. Németh, P. Rosenberger, H. K. Eltzschig, Z. Spolarics, P. Pacher, Z. Selmeczy, B. Koscsó, L. Himer, E. S. Vizi, et al. 2010. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J. Immunol. 185: 542-550.
29. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
30. Haskó, G., and P. Pacher. 2008. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J. Leukoc. Biol. 83: 447-455. (Pubitemid 351966849)
31. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405. (Pubitemid 39657287)
32. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992. (Pubitemid 39620148)
33. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796. (Pubitemid 37087777)
34. Gessi, S., S. Merighi, K. Varani, E. Leung, S. Mac Lennan, and P. A. Borea. 2008. The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol. Ther. 117: 123-140. (Pubitemid 350192673)
35. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265. (Pubitemid 46919862)
36. Ernst, P. B., J. C. Garrison, and L. F. Thompson. 2010. Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol. 185: 1993-1998.
37. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188: 1433-1443. (Pubitemid 28489580)
38. Volmer, J. B., L. F. Thompson, and M. R. Blackburn. 2006. Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J. Immunol. 176: 4449-4458. (Pubitemid 44264425)
39. Eckle, T., L. Füllbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. Ibla, P. Rosenberger, and H. K. Eltzschig. 2007. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178: 8127-8137. (Pubitemid 46898085)
40. Montesinos, M. C., M. Takedachi, L. F. Thompson, T. F. Wilder, P. Fernández, and B. N. Cronstein. 2007. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5′-nucleotidase: findings in a study of ecto-5′-nucleotidase gene-deficient mice. Arthritis Rheum. 56: 1440-1445. (Pubitemid 46764071)
41. Reutershan, J., I. Vollmer, S. Stark, R. Wagner, K.-C. Ngamsri, and H. K. Eltzschig. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23: 473-482.
42. Eckle, T., A. Grenz, S. Laucher, and H. K. Eltzschig. 2008. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118: 3301-3315.
43. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
44. Grenz, A., H. Zhang, T. Eckle, M. Mittelbronn, M. Wehrmann, C. Köhle, D. Kloor, L. F. Thompson, H. Osswald, and H. K. Eltzschig. 2007. Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J. Am. Soc. Nephrol. 18: 833-845. (Pubitemid 46434500)
45. Eckle, T., T. Krahn, A. Grenz, D. Köhler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, and H. K. Eltzschig. 2007. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590. (Pubitemid 46648643)
46. Senthil, M., A. Watkins, D. Barlos, D. Z. Xu, Q. Lu, B. Abungu, F. Caputo, R. Feinman, and E. A. Deitch. 2007. Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway. Ann. Surg. 246: 822-830. (Pubitemid 350035659)
47. Csóka, B., Z. H. Németh, P. Mukhopadhyay, Z. Spolarics, M. Rajesh, S. Federici, E. A. Deitch, S. Bátkai, P. Pacher, and G. Haskó. 2009. CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS ONE 4: e6409.
48. Nevière, R., H. Fauvel, C. Chopin, P. Formstecher, and P. Marchetti. 2001. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am. J. Respir. Crit. Care Med. 163: 218-225. (Pubitemid 32095273)
49. Jo, S. K., D. R. Cha, W. Y. Cho, H. K. Kim, K. H. Chang, S. Y. Yun, and N. H. Won. 2002. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 91: 406-415. (Pubitemid 34765238)
50. Hiramatsu, M., R. S. Hotchkiss, I. E. Karl, and T. G. Buchman. 1997. Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7: 247-253. (Pubitemid 127654275)
51. Xu, N., X.-P. Gao, R. D. Minshall, A. Rahman, and A. B. Malik. 2002. Time-dependent reversal of sepsis-induced PMN uptake and lung vascular injury by expression of CD18 antagonist. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L796-L802. (Pubitemid 34665596)
52. Rosenberg, I. K., S. L. Gupta, C. E. Lucas, A. A. Khan, and B. F. Rosenberg. 1971. Renal insufficiency after trauma and sepsis. A prospective functional and ultrastructural analysis. Arch. Surg. 103: 175-183.
53. Lee, H. T., H. Xu, S. H. Nasr, J. Schnermann, and C. W. Emala. 2004. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am. J. Physiol. Renal Physiol. 286: F298-F306. (Pubitemid 38141673)
54. Morikawa, A., T. Sugiyama, Y. Kato, N. Koide, G. Z. Jiang, K. Takahashi, Y. Tamada, and T. Yokochi. 1996. Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect. Immun. 64: 734-738. (Pubitemid 26065541)
55. Lee, H. T., G. Gallos, S. H. Nasr, and C. W. Emala. 2004. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J. Am. Soc. Nephrol. 15: 102-111. (Pubitemid 38020702)
56. Joo, J. D., M. Kim, P. Horst, J. Kim, V. D. D'Agati, C. W. Emala, Sr., and H. T. Lee. 2007. Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am. J. Physiol. Renal Physiol. 293: F1847-F1857. (Pubitemid 350179610)
57. Wang, S. D., K. J. Huang, Y. S. Lin, and H. Y. Lei. 1994. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152: 5014-5021.
58. Guo, R. F., M. Huber-Lang, X. Wang, V. Sarma, V. A. Padgaonkar, R. A. Craig, N. C. Riedemann, S. D. McClintock, T. Hlaing, M. M. Shi, and P. A. Ward. 2000. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106: 1271-1280.
59. Tinsley, K. W., S. L. Cheng, T. G. Buchman, K. C. Chang, J. J. Hui, P. E. Swanson, I. E. Karl, and R. S. Hotchkiss. 2000. Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 13: 1-7.
60. Hotchkiss, R. S., P. E. Swanson, J. P. Cobb, A. Jacobson, T. G. Buchman, and I. E. Karl. 1997. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit. Care Med. 25: 1298-1307. (Pubitemid 27347292)
61. Fearnhead, H. O., D. Dinsdale, and G. M. Cohen. 1995. An interleukin-1 beta-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett. 375: 283-288. (Pubitemid 3002970)
62. Böhrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Männel, B. W. Böttiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFkappaB in the mortality of sepsis. J. Clin. Invest. 100: 972-985.
63. Foulds, S., C. Galustian, A. O. Mansfield, and M. Schachter. 2001. Transcription factor NF kappa B expression and postsurgical organ dysfunction. Ann. Surg. 233: 70-78. (Pubitemid 32042778)
64. Joshi, A. R., C. S. Chung, G. Y. Song, J. Lomas, R. A. Priester, and A. Ayala. 2002. NF-kappaB activation has tissue-specific effects on immune cell apoptosis during polymicrobial sepsis. Shock 18: 380-386.
65. Haskó, G., M. V. Sitkovsky, and C. Szabó. 2004. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol. Sci. 25: 152-157. (Pubitemid 38264506)
66. Cohen, E. S., W. R. Law, C. R. Easington, K. Q. Cruz, B. A. Nardulli, R. A. Balk, J. E. Parrillo, and S. M. Hollenberg. 2002. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis. Am. J. Respir. Crit. Care Med. 166: 16-20. (Pubitemid 34693957)
67. Firestein, G. S., D. Boyle, D. A. Bullough, H. E. Gruber, F. G. Sajjadi, A. Montag, B. Sambol, and K. M. Mullane. 1994. Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol. 152: 5853-5859. (Pubitemid 24174165)
68. Cronstein, B. N., L. Daguma, D. Nichols, A. J. Hutchison, and M. Williams. 1990. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85: 1150-1157. (Pubitemid 20123757)
69. Chen, Y., R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel, and W. G. Junger. 2006. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795. (Pubitemid 44969094)
70. Nakav, S., C. Chaimovitz, Y. Sufaro, E. C. Lewis, G. Shaked, D. Czeiger, M. Zlotnik, and A. Douvdevani. 2008. Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PLoS ONE 3: e2107.
71. Cronstein, B. N., R. I. Levin, M. Philips, R. Hirschhorn, S. B. Abramson, and G. Weissmann. 1992. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J. Immunol. 148: 2201-2206.
72. Alam, M. S., C. C. Kurtz, R. M. Rowlett, B. K. Reuter, E. Wiznerowicz, S. Das, J. Linden, S. E. Crowe, and P. B. Ernst. 2009. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J. Infect. Dis. 199: 494-504.
73. Hasegawa, T., D. Bouïs, H. Liao, S. H. Visovatti, and D. J. Pinsky. 2008. Ecto-5′ nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ. Res. 103: 1410-1421.
74. Hart, M. L., M. Henn, D. Köhler, D. Kloor, M. Mittelbronn, I. C. Gorzolla, G. L. Stahl, and H. K. Eltzschig. 2008. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J. 22: 2784-2797.
75. Song, G. Y., C. S. Chung, I. H. Chaudry, and A. Ayala. 2000. Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. J. Surg. Res. 91: 141-146. (Pubitemid 30445588)
76. Bommhardt, U., K. C. Chang, P. E. Swanson, T. H. Wagner, K. W. Tinsley, I. E. Karl, and R. S. Hotchkiss. 2004. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 172: 7583-7591. (Pubitemid 38747622)
77. Milton, S. L., L. J. Dirk, L. F. Kara, and H. M. Prentice. 2008. Adenosine modulates ERK1/2, PI3K/Akt, and p38MAPK activation in the brain of the anoxia-tolerant turtle Trachemys scripta. J. Cereb. Blood Flow Metab. 28: 1469-1477.
78. Javadi, P., T. G. Buchman, P. E. Stromberg, K. D. Husain, W. M. Dunne, C. A. Woolsey, I. R. Turnbull, R. S. Hotchkiss, I. E. Karl, and C. M. Coopersmith. 2004. High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit. Care Med. 32: 1178-1185. (Pubitemid 38620988)